>.... are these PCT patent applications of patents already granted in the US?<
Good question! I'll do some research -
From the MNTA site -
Over 100 patents give Momenta a strong proprietary position. Momenta possesses a strong intellectual property position around our characterization platform. We license or own a total of over 100 patents and patent applications. Our patent portfolio includes claims covering:
•methods and technologies for characterizing sugars; •the use of certain enzymes and reagents that specifically recognize polysaccharides in the characterization of sugars; •methods and technologies for chemical and metabolic synthesis of sugars; •the composition of matter of certain novel low-molecular-weight herapins (LMWHs), including M118, and heparinase variants; •methods to produce and identify sugars associated with glycoproteins; •methods to analyze and monitor glycoprotein profiles for purposes associated with the diagnosis, staging, prognosis and monitoring of cancer; and •methods for the in vivo non-invasive delivery of sugars. We also rely on trade secrets, know-how, continuing technological innovation and in-licensing opportunities to develop and maintain our proprietary position.
Market Data 
Markets 
AI
